Feb 1 (Reuters) - Palla Pharma Ltd (PAL) :
- MARKET UPDATE - UK MAS, CURRENT TRADING AND BUSINESS REVIEW-PAL.AX
- MHRA GRANTS APPLICATIONS TO CHANGE SITE OF MANUFACTURE OF CO-CODAMOL TABLET & CAPLET MARKETING AUTHORISATIONS TO NORWAY FACILITY
- DELAY OF RECEIPT OF FINAL APPROVALS FROM MHRA CAUSED CO TO GENERATE GREATER THAN EXECTED OPERATING LOSSES IN FINAL QUARTER OF 2020
- LOSSES HAVE CONTINUED INTO 2021
(([email protected];))